| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 540 | $90 | $48.9K |
| J7999 | Compounded drug, not otherwise classified | 480 | $70 | $31.7K |
| 92273 | The provider performs an electrophysiologic test of retinal function, which may be referred to as conventional, full–field or Ganzfeld (ffERG) or flash/focal (fERG) electroretinography to assess… | 320 | $100 | $30K |
| 67210 | The provider destroys a lesion of the retina using a laser beam that heats up the tissue. | 50 | $410 | $21.4K |
| 92242 | The provider injects two different special dyes into one or both eyes that cause the blood vessels to stand out in photographic images timed so that multiple frames are taken in rapid succession. He… | 80 | $200 | $16.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 150 | $100 | $14.9K |
| 92235 | The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken… | 140 | $110 | $14.3K |
| 67228 | In retinopathy, tiny new vessels grow profusely and fibrous tissue proliferates in between the layers of the retina, which may extend into the optic nerve and vitreous, clear gel that fills the space… | 50 | $270 | $14.2K |
| 76512 | The provider uses B–scan ultrasound imaging, with or without a non–qualitative A–scan superimposed, to examine the intraocular and orbital structures. | 250 | $50 | $13.6K |
| 76510 | The provider uses B–scan and quantitative A–scan ultrasound imaging to examine the intraocular and orbital structures. | 150 | $80 | $12.4K |